ViaDerma (VDRM)
OTHER OTC:VDRM
US Market
Holding VDRM?
Track your performance easily

ViaDerma (VDRM) Income Statement

63 Followers

ViaDerma Income Statement

Last quarter (Q ), ViaDerma's total revenue was $5.82M, an increase of 0.19% from the same quarter last year. In Q, ViaDerma's net income was $954.83K. See ViaDerma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 11Dec 10Dec 09Dec 08Dec 07
Total Revenue
$ 17.80M$ 19.01M$ 26.83M$ 25.26M$ 25.67M$ 17.96K
Cost of Revenue
$ 12.66M$ 13.35M$ 16.68M$ 14.28M$ 15.11M-
Gross Profit
$ 5.14M$ 5.66M$ 10.15M$ 10.98M$ 10.56M-
Operating Expense
$ 1.40M$ 1.62M$ 2.38M$ 4.59M$ 1.55M$ 159.44K
Operating Income
$ 3.74M$ 4.04M$ 7.77M$ 6.39M$ 9.01M$ -141.48K
Net Non Operating Interest Income Expense
$ -660.62K$ -489.89K$ -1.26M$ -327.84K$ -292.71K-
Other Income Expense
-$ -1.54K$ -1.43K---
Pretax Income
$ 3.08M$ 3.55M$ 6.50M$ 6.07M$ 8.72M-
Tax Provision
$ 767.00K$ 874.34K$ 1.99M$ 1.97M$ 2.16M-
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ 2.31M$ 2.67M$ 4.51M$ 4.09M$ 6.55M$ -141.48K
Basic EPS
$ 17.00$ 19.50$ 33.00$ 30.00$ 49.50$ -12.60
Diluted EPS
$ 17.00$ 19.50$ 33.00$ 30.00$ 49.50$ -12.60
Basic Average Shares
$ 549.29K$ 137.32K$ 137.32K$ 135.05K$ 133.33K$ 11.38K
Diluted Average Shares
$ 549.29K$ 137.32K$ 137.32K$ 138.37K$ 133.33K$ 11.38K
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 14.06M$ 14.97M$ 19.06M$ 18.87M$ 16.66M$ 159.44K
Net Income From Continuing And Discontinued Operation
$ 2.31M$ 2.67M$ 4.51M$ 4.09M$ 6.55M$ -141.48K
Normalized Income
$ 2.31M$ 2.67M$ 4.51M$ 4.09M$ 6.55M$ -141.48K
Interest Expense
$ 675.30K$ 502.36K$ 1.27M$ 329.57K$ 295.70K-
EBIT
$ 3.75M$ 4.05M$ 7.77M$ 6.40M$ 9.01M$ -141.48K
EBITDA
$ 6.85M$ 6.86M$ 9.33M$ 7.05M$ 9.44M$ -139.86K
Currency in USD

ViaDerma Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis